PharmaDrug Inc.: PharmaDrug Advances Programs in Oncology with Filing of PCT Application Detailing the Use of PD-001 for Treatment of Prostate Cancer
Toronto, Ontario--(Newsfile Corp. - January 31, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development
United States Wangy Cepharanthine Daniel Cohen Baillyc Cepharanthine Newsfile Corp Development Paths For Oncology
Source: finanznachrichten.de